21 November, 2018
Kista, November 21 2018. Chordate CEO Anders Weilandt will participate in the live event by BioStock discussing the subject: “Exploring the future of diagnostics & med tech” on November 27, 2018 at 10 AM CET.
Read more about the event at https://www.live.biostock.se. The Chordate slot of presentation will commence at 10:25 and the presentation will be held in English.
For more information, please contact:Anders Weilandt, CEOanders.firstname.lastname@example.orgTelefon: +46 (0) 733 87 42 77
If you want to read our press releases, there are available in the Investor Relations section or by clicking the link below.
For questions about Chordate's share price or other investment-related topics, please see if the answer is here.
For questions about the medical effects of the K.O.S treatment, please see if the answer is here.
To get in touch with Chordate regarding other questions, use the adjecent form. We do our best to respond as quickly as possible.